Global Oncothon 2026
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy
PRADO Trial: Neoadjuvant Ipilimumab Plus Nivolumab in Melanoma—5-Year Survival and Biomarker Analysis
In Memory of Kirsty Duncan: A Life Devoted to Science, Health, and Equity
Community Oncology Alliance Shares 2025 End of Year Update on Advocacy and Practice Support
How the European Code Against Cancer Can Reduce Cancer Risk in Greece - ELLOK
Afreen Shariff Starts a New Position as Chair at ASCO for the ASPIRE Community of Practice
Breakthrough Innovations in Frontline TNBC Care - The Breast Friends Podcast
